Af­ter ran­corous threats and a clin­i­cal hold, Ap­plied Ther­a­peu­tics is set to re­sume pe­di­atric galac­tosemia study

Af­ter an anony­mous re­port raised red flags over Ap­plied Ther­a­peu­tics’ in­tegri­ty in Ju­ly, say­ing the com­pa­ny “cher­ry picked” da­ta and os­ten­si­bly prompt­ing a short at­tack …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER